Evaluation of serological tests for SARS-CoV-2: Implications for serology testing in a low-prevalence setting release_7fwzwudbrnh75jqfjcsgwze4cq

by Katherine Bond, Suellen Nicholson, Seok Lim, Theo Karapanagiotidis, Eloise Williams, Douglas Johnston, Tuyet Hoang, Cheryll Sia, Damian Purcell, Sharon Lewin, Mike Catton, Benjamon P Howden (+1 others)


NOTE: currently batch computed and may include additional references sources, or be missing recent changes, compared to entity reference list.
Fuzzy reference matching is a work in progress!
Read more about quality, completeness, and caveats in the fatcat guide.
Showing 1 - 22 of 22 references (in 170ms)

via crossref
A new coronavirus associated with human respiratory disease in China
Fan Wu, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhi-Gang Song, Yi Hu, Zhao-Wu Tao (+ more)
2020   Nature
doi:10.1038/s41586-020-2008-3  pmcid:PMC7094943  pmid:32015508 
web.archive.org [PDF]

via grobid
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;

via crossref
A Genomic Perspective on the Origin and Emergence of SARS-CoV-2
Yong-Zhen Zhang, Edward C Holmes
2020   Cell
doi:10.1016/j.cell.2020.03.035  pmcid:PMC7194821  pmid:32220310 
web.archive.org [PDF]

via grobid
Cell. 2020; 181(2):223-227.

via crossref
The Promise and Peril of Antibody Testing for COVID-19
Jennifer Abbasi
2020   Journal of the American Medical Association (JAMA)
doi:10.1001/jama.2020.6170  pmid:32301958 
web.archive.org [PDF]

via crossref
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M Corman, Olfert Landt, Marco Kaiser, Richard Molenkamp, Adam Meijer, Daniel KW Chu, Tobias Bleicker, Sebastian Brünink (+ more)
2020   Eurosurveillance
doi:10.2807/1560-7917.es.2020.25.3.2000045  pmcid:PMC6988269  pmid:31992387 
web.archive.org [PDF]

via grobid
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020 Jan;25(3).

via crossref
Developing antibody tests for SARS-CoV-2
Anna Petherick
2020   The Lancet
doi:10.1016/s0140-6736(20)30788-1  pmid:32247384 
web.archive.org [PDF]

via grobid
Petherick A. Developing antibody tests for SARS-CoV-2. Lancet. 2020 Apr 4;395(10230):1101-1102.

via crossref
A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease [post]
Angkana T. Huang, Bernardo Garcia-Carreras, Matt D.T. Hitchings, Bingyi Yang, Leah Katzelnick, Susan M Rattigan, Brooke Borgert, Carlos Moreno (+ more)
doi:10.1101/2020.04.14.20065771  pmcid:PMC7217088  pmid:32511434 
web.archive.org [PDF]

via grobid
Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick L, Rattigan SM, et al. A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease. medRxiv. 2020:2020.04.14.20065771.

via grobid
Royal College of Pathologists Australasia (RCPA). Position Statement: COVID19 IgG/IgM

via crossref
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients
Nisreen M A Okba, Marcel A Müller, Wentao Li, Chunyan Wang, Corine H GeurtsvanKessel, Victor M Corman, Mart M Lamers, Reina S Sikkema (+ more)
2020   Emerging Infectious Diseases
doi:10.3201/eid2607.200841  pmcid:PMC7323511  pmid:32267220 
web.archive.org [PDF]

via crossref
Evaluation of nine commercial SARS-CoV-2 immunoassays [post]
Ria Lassaunière, Anders Frische, Zitta B Harboe, Alex CY Nielsen, Anders Fomsgaard, Karen A Krogfelt, Charlotte S Jørgensen
2020    unpublished
web.archive.org [PDF]

via crossref
Neutralizing Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort and Their Implications
Fan Wu, Aojie Wang, Mei Liu, Qimin Wang, Jun Chen, Shuai Xia, Yun Ling, Yuling Zhang (+ more)
2020   Social Science Research Network

via grobid
Lassaunière R, Frische A, Harboe ZB, Nielsen AC, Fomsgaard A, Krogfelt KA, et al.

via crossref
Implications of test characteristics and population seroprevalence on 'immune passport' strategies
Daniel B Larremore, Kate M Bubar, Yonatan H Grad
2020   Clinical Infectious Diseases
doi:10.1093/cid/ciaa1019  pmid:32687149 
web.archive.org [PDF]

via crossref
Laboratory Diagnosis of HIV in Adults: A Review of Current Methods
J. K. Cornett, T. J. Kirn
2013   Clinical Infectious Diseases
doi:10.1093/cid/cit281  pmid:23667267 
web.archive.org [PDF]

via grobid
Wu F, Wang A, Liu M, Wang Q, Chen J, Xia S, et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv. 2020:2020.03.30.20047365.

via grobid
Australian Government Department of Health. Coronavirus (COVID-19) Current situation and case numbers. 2020. Available from: https://www.health.gov.au/news/health-alerts/novel- coronavirus-2019-ncov-health-alert/coronavirus-covid-19-current-situation-and-case-numbers, last accessed 6 th May, 2020.

via grobid
Larremore DB, Kate M. Bubar, and Yonatan H. Grad. Implications of test characteristics and population seroprevalence on 'immune passport' strategies. May 2020. Available at https://dash.harvard.edu/handle/1/42664007?show=full, last accessed 15 th May, 2020

via grobid
Cornett JK, Kirn TJ. Laboratory diagnosis of HIV in adults: a review of current methods. Clin Infect Dis 2013;57(5):712-8.